Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunotherapy in Melanoma: Recent Advancements and Future Directions. | Cancers (Basel) | 2023 | 37627204 | PubTator, text mining | PubMed |
| Analysis of tumor infiltrating CD4+ and CD8+ CDR3 sequences reveals shared features putatively associated to the anti-tumor immune response. | Front Immunol | 2023 | 37600765 | PubTator, text mining | PubMed |
| Challenges and new technologies in adoptive cell therapy. | J Hematol Oncol | 2023 | 37596653 | PubTator, text mining | PubMed |
| BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens. | Genome Biol | 2023 | 37582761 | PubTator, text mining | PubMed |
| Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers. | Int J Mol Sci | 2023 | 37569782 | PubTator, text mining | PubMed |
| Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy. | Int J Mol Sci | 2023 | 37569548 | PubTator, text mining | PubMed |
| H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy. | J Immunother Cancer | 2023 | 37553181 | PubTator, text mining | PubMed |
| Guanylate-binding proteins signature predicts favorable prognosis, immune-hot microenvironment, and immunotherapy response in hepatocellular carcinoma. | Cancer Med | 2023 | 37551111 | PubTator, text mining | PubMed |
| Identification of the relationship between single-cell N6-methyladenosine regulators and the infiltrating immune cells in esophageal carcinoma. | Heliyon | 2023 | 37529341 | PubTator, text mining | PubMed |
| Recent Advancement in mRNA Vaccine Development and Applications. | Pharmaceutics | 2023 | 37514158 | PubTator, text mining | PubMed |
| Virus-Based Biological Systems as Next-Generation Carriers for the Therapy of Central Nervous System Diseases. | Pharmaceutics | 2023 | 37514117 | PubTator, text mining | PubMed |
| Maintenance Treatment for Metastatic Pancreatic Cancer: Balancing Therapeutic Intensity with Tolerable Toxicity. | Cancers (Basel) | 2023 | 37509318 | PubTator, text mining | PubMed |
| The MAGE A1-A10 Expression associated with Histopathological Findings of Malignant or Non-Malignant Cells in Peripheral Lung Tumors. | Asian Pac J Cancer Prev | 2023 | 37505763 | PubTator, text mining | PubMed |
| Pathology and Molecular Biology of Melanoma. | Curr Issues Mol Biol | 2023 | 37504268 | PubTator, text mining | PubMed |
| Multi-tiered approach to detect autoimmune cross-reactivity of therapeutic T cell receptors. | Sci Adv | 2023 | 37494434 | PubTator, text mining | PubMed |
| Immunotherapy: an emerging modality to checkmate brain metastasis. | Mol Cancer | 2023 | 37454123 | PubTator, text mining | PubMed |
| Immunotherapy for Recurrent Glioma-From Bench to Bedside. | Cancers (Basel) | 2023 | 37444531 | PubTator, text mining | PubMed |
| Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments. | J Transl Med | 2023 | 37420216 | PubTator, text mining | PubMed |
| The use of RNA-based treatments in the field of cancer immunotherapy. | Mol Cancer | 2023 | 37420174 | PubTator, text mining | PubMed |
| Bibliometric and visualized analysis of the top-100 highly cited articles on immunotherapy for endometrial cancer. | Medicine (Baltimore) | 2023 | 37417594 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=10